Trulieve Cannabis (TCNNF) Receivables - Other (2022 - 2023)
Trulieve Cannabis (TCNNF) recorded quarterly Receivables - Other of $22.5 million in Q2 2023, little changed quarter-over-quarter from $22.5 million in Q4 2022.
Trulieve Cannabis (TCNNF) Receivables - Other (2022 - 2023) Analysis & Trends
Trulieve Cannabis' Receivables - Other history runs 2 years deep, the most recent figure standing at $22.5 million for Q2 2023.
- In Q2 2023, Receivables - Other changed N/A year-over-year to $22.5 million; the TTM figure through Jun 2023 stood at $22.5 million (changed N/A YoY), while the FY2022 annual figure was $22.5 million, changed N/A from the prior year.
- Receivables - Other was $22.5 million for Q2 2023 at Trulieve Cannabis, roughly flat from $22.5 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $22.5 million in Q2 2023 to a low of $100000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 22.50 Mn |
| Jun 30, 2023 | 22.50 Mn |
| Dec 31, 2022 | 22.50 Mn |
| Dec 31, 2022 | 22.50 Mn |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 10.00 Mn |
| Mar 31, 2022 | 10.00 Mn |